GLUCO RX LIMITED
Get an alert when GLUCO RX LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-04-07 (in 11mo)
Last made up 2026-03-24
Watchouts
None on the register
Cash
£4M
-1.6% lowest in 5 filed years
Net assets
£101M
+15.9% highest in 3 filed years
Employees
54
+10.2% vs 2024
Profit before tax
—
Period ending 2025-03-31
Cash
7-year trend · vs Health Care median
Accounts
7-year trend · latest reflected 2025-03-31
| Metric | Trend | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | — | — | |
| Net profit | — | — | — | — | — | £12,396,901 | £13,877,364 | |
| Cash | — | — | £29,651,494 | £38,515,036 | £25,706,404 | £3,829,817 | £3,768,662 | |
| Total assets less current liabilities | — | — | £45,445,462 | — | — | £87,551,665 | £101,438,858 | |
| Net assets | — | — | — | — | — | — | — | |
| Equity | £35,559,152 | £30,839,874 | £45,445,462 | £61,531,086 | £75,427,043 | £87,500,995 | £101,378,359 | |
| Average employees | — | — | 63 | — | — | 49 | 54 | |
| Wages | — | — | — | — | — | £2,023,553 | £2,252,331 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Cheesmans
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- GLUCO RX LIMITED · parent
- GlucoRX Technologies Limited 100%
- Borg Pharma Limited 100%
- Pharmacy Link Limited 100%
- Microvisk Technologies Limited 100%
- Microvisk Limited 100%
- Microvisk Technologies International Limited 100%
- Conker PJ Limited 100%
- Gluco RX Healthcare Private Limited 100%
- Gluco RX Europe Limited 100%
Significant events
- “Expansion of Portfolio: Broadening offerings in diabetes and other therapeutic areas, including cardiovascular and pain management.”
- “Globalisation Strategy: Transitioning from a UK-centric model to a global healthcare provider, leveraging success in the UK to penetrate international markets.”
- “R&D Innovation: Investing in ground breaking, non-invasive technologies and multiparameter monitoring systems.”
- “Phase 1: India (Operational): GlucoRx has already commenced operations in India through GlucoRx Healthcare Private Limited, based in Mumbai.”
- “Phase 2: MENA Region (Upcoming): Building on the momentum in India, the company is preparing to enter the Middle East and North Africa (MENA) region.”
- “Phase 3: Australasia (Future Expansion): The final stage of the current globalisation roadmap involves expanding into Australasia.”
- “Phase 4: With our own patented new products, we shall be entering into the lucrative UK, Europe and USA markets.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KHIROYA, Parag | Director | 2011-02-02 | May 1963 | British |
| NATHWANI, Nilesh | Director | 2011-02-02 | Jul 1961 | British |
| NATHWANI, Panna | Director | 2016-03-31 | Jan 1964 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHAPMAN, Chris | Director | 2015-07-30 | 2019-09-12 |
| KHIROYA, Varsha | Director | 2016-03-31 | 2025-03-24 |
| KHIROYA, Varsha | Director | 2013-04-01 | 2016-03-30 |
| NATHWANI, Panna | Director | 2013-04-01 | 2016-03-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Parag Khiroya | Individual | Shares 25–50%, Voting 25–50% | 2025-03-24 | Active |
| Mr Nilesh Nathwani | Individual | Shares 25–50%, Voting 25–50% | 2025-03-24 | Active |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-19 | AA | accounts | Accounts with accounts type group | |
| 2025-11-03 | CH01 | officers | Change person director company with change date | |
| 2025-11-03 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-10-27 | CH01 | officers | Change person director company with change date | |
| 2025-10-27 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2025-04-02 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-02 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-04-02 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-04-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-01 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2025-03-26 | AA | accounts | Accounts with accounts type group | |
| 2025-02-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-19 | AA | accounts | Accounts with accounts type group | |
| 2023-09-12 | SH01 | capital | Capital allotment shares | |
| 2023-07-27 | RESOLUTIONS | resolution | Resolution | |
| 2023-07-27 | MA | incorporation | Memorandum articles | |
| 2023-03-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-12-19 | AA | accounts | Accounts with accounts type group |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
—
Not reported
-
Cash
-1.6%
£3,829,817 £3,768,662
lowest in 5 filed years
-
Net assets
—
Not reported
-
Employees
+10.2%
49 54
-
Wages
+11.3%
£2,023,553 £2,252,331
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers